CDC gathers to discuss which patient groups should get Moderna and J&J COVID-19 vaccine boosters, and Pfizer reports positive results from booster trial

Posted on AllSides October 21st, 2021
From The Center
HAZEM BADER/AGENCE FRANCE-PRESSE/GETTY IMAGES

There was a flurry of positive news on vaccine boosters Thursday, as the Centers for Disease Control and Prevention gathered to discuss which patient groups should be eligible for boosters developed by Moderna and Johnson & Johnson.

The meeting follows a decision Wednesday by the Food and Drug Administration to allow those boosters, marking a big step toward expanding the booster campaign, which started with extra doses of the vaccine developed by Pfizer PFE, +0.14% and German partner BioNTech BNTX, +6.29% last month. The CDC will now consult an expert panel Thursday before finalizing official recommendations...

Read full story
https://www.marketwatch.com/story/cdc-gathers-to-discuss-which-patient-groups-should-get-moderna-and-j-j-covid-19-vaccine-boosters-and-pfizer-reports-positive-results-in-booster-trial-11634826920

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right